Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:157103.
doi: 10.1155/2013/157103. Epub 2013 May 12.

HMGB1: A Promising Therapeutic Target for Prostate Cancer

Munirathinam Gnanasekar  1 , Ramaswamy Kalyanasundaram, Guoxing Zheng, Aoshuang Chen, Maarten C Bosland, André Kajdacsy-Balla
Affiliations

HMGB1: A Promising Therapeutic Target for Prostate Cancer

Munirathinam Gnanasekar et al. Prostate Cancer. 2013.

Abstract

High mobility group box 1 (HMGB1) was originally discovered as a chromatin-binding protein several decades ago. It is now increasingly evident that HMGB1 plays a major role in several disease conditions such as atherosclerosis, diabetes, arthritis, sepsis, and cancer. It is intriguing how deregulation of HMGB1 can result in a myriad of disease conditions. Interestingly, HMGB1 is involved in cell proliferation, angiogenesis, and metastasis during cancer progression. Furthermore, HMGB1 has been demonstrated to exert intracellular and extracellular functions, activating key oncogenic signaling pathways. This paper focuses on the role of HMGB1 in prostate cancer development and highlights the potential of HMGB1 to serve as a key target for prostate cancer treatment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed model of HMGB1 mediated prostate cancer progression.
See this image and copyright information in PMC

References

    1. Divrik RT, Turkeri L, Sahin AF, et al. Prediction of response to androgen deprivation therapy and castration resistance in primary metastatic prostate cancer. Urologia Internationalis. 2012;88:25–33. - PubMed
    1. Ellerman JE, Brown CK, De Vera M, et al. Masquerader: high mobility group box-1 and cancer. Clinical Cancer Researchearch. 2007;13(10):2836–2848. - PubMed
    1. Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1 and cancer. Biochimica et Biophysica Acta. 2010;1799(1-2):131–140. - PMC - PubMed
    1. Gnanasekar M, Thirugnanam S, Ramaswamy K. Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis. International Journal of Oncology. 2009;34(2):425–431. - PubMed
    1. Štros M. HMGB proteins: interactions with DNA and chromatin. Biochimica et Biophysica Acta. 2010;1799(1-2):101–113. - PubMed

LinkOut - more resources